Arkolith/Insider Trading/CASI/Form 4

He Wei-Wu

Chairman and CEO, DirectorCASI Pharmaceuticals, Inc. (CASI) · full profile →Form 4 · filed Nov 19, 2021
Net Buying
Open-Market Buys
$394K
Open-Market Sells
$0
Net Open-Market Flow
$394K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2021Buy(P)200K$0.98$196K5.6M
Nov 17, 2021Buy(P)200K$0.99$198K5.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-141867) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML